CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Birzeit Pharmaceutical Company Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Birzeit Pharmaceutical Company Ltd
P.O.Box 43
Phone: +970 22987572p:+970 22987572 RAMALLAH, Palestine Ticker: BPCBPC
Business Summary
Birzeit Pharmaceutical Company Ltd is a Palestine-based pharmaceutical company engaged in manufacturing and distributing generic medicines products in a variety of therapeutic fields. The Company manufactures and markets more than 300 products distributed among ten lines of production: Ampoules, Capsules, Tablets and Caplets, Syrups, Suspensions and Granules, Ophthalmic, Semi-solids, Powder vials, Suppositories and Powders. In addition to customers in the local Palestinian market, including Ministry of Health, local health care organizations, international health care organizations and programs, the Company has also presence in different export markets, mainly Algeria and East Europe. The Company also operates through its subsidiaries included Palestine Printing and Publishing Company and Midex for Medical Supplies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023Yes----

Industries
SIC Code Description
2833 Medicinal chemicals and botanical products
2834 Pharmaceutical preparations

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager Talal Q.Naser Alddin 1/1/1990 4/1/1984
Vice Chairman of the Board Mohammed N.Naser Alddin 4/30/1984 4/30/1984
Deputy General Manager, Assistant General Manager for Technical Affairs Jumaa M.Khalaf
11 additional Officers and Directors records available in full report.

Business Names
Business Name
Birzeit Pharmaceuticals Company
BPC

General Information
Number of Employees: 375 (As of 12/31/2022)
Outstanding Shares: 38,764,898 (As of 12/31/2023)
Shareholders: 1,421
Stock Exchange: PAS
Fax Number: +970 22967205


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, April 26, 2024